KERRI MCANULTY: Open Payments
NPI 1144696931 · JEANNETTE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,815 in 107 payments from 13 companies in 2025. Trend: 2023 $739 · 2024 $874 · 2025 $1,815
Food & beverage: $1,704Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 53 | $595 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $286 |
| Vanda Pharmaceuticals Inc. | 13 | $285 |
| Teva Pharmaceuticals USA, Inc. | 4 | $183 |
| Otsuka America Pharmaceutical, Inc. | 4 | $110 |
| Lundbeck LLC | 4 | $89 |
| Alkermes, Inc. | 4 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
Products named: VRAYLAR, CAPLYTA, HETLIOZ, REXULTI, ARISTADA, FANAPT, UZEDY, TRINTELLIX.
Industry payments across PA — which companies pay providers there.
